02/27/2025 6:57 AM | BioNTech (Subject) Richardson Ryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 6:53 AM | BioNTech (Subject) Medine GmbH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025 6:50 AM | BioNTech (Subject) Poetting Sierk (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025 6:02 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025 5:58 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:25 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 6:21 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024 4:56 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024 4:25 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 5:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 4:57 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter.
|
11/27/2024 4:50 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024 5:37 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024 4:06 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 6:38 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 5:49 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024 5:57 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2024 8:04 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024 4:03 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 7:41 AM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024 3:15 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024 3:13 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 3:24 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024 3:17 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 4:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024 5:18 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024 7:12 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 3:52 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024 4:12 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024 6:14 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024 8:17 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 6:28 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024 4:35 PM | ATHOS KG (Reporting) BioNTech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024 7:53 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/22/2024 3:31 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024 7:34 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024 5:56 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024 5:32 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/05/2024 5:34 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024 8:08 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know.
Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month.
This backdoor strategy is changing the game for smart investors.
Want to see how it works? Click here to uncover Tesla's hidden income secret. |
06/24/2024 7:07 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 6:18 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024 6:46 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 3:36 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024 6:18 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024 5:48 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 4:05 PM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 6:12 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 6:57 AM | BioNTech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/20/2024 6:33 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 6:11 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 8:04 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 7:41 AM | BioNTech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |